| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Cancer Institute, NIH, Bethesda, Maryland 20014
3 Reprint requests to: Dr. Seymour Perry, National Cancer Institute, Building 10, Room 6B17, Bethesda, Maryland 20014.
Four clinically active antileukemic drugs were applied to six long-term human leukocyte cultures, derived from patients with acute and chronic myelogenous leukemia, lymphosarcoma, and Burkitt's lymphoma, to a cell line isolated from the peripheral blood of a normal individual and to a line prepared from ascitic lymphocytes of L1210 mouse leukemia. Dose-response and cell exposure time-response curves were obtained in vitro for each of the cytotoxic test agents. These studies provide new insight into the C x T relationships of the four test drugs and indicate that the long-term human leukocyte culture model may be useful in the evaluation of some of the factors determining the effectiveness of a drug as a chemotherapeutic agent.
1 Present address: Sloan-Kettering Institute for Cancer Research, New York, New York.
2 Division of Computer Research and Technology, NIH, Bethesda, Maryland.
Received 9/26/68. Accepted 5/13/69.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |